XNAS 27 Jun, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Jennifer Phipps | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 21.75 per share. | 12 Jun 2025 | 15,616 | 230,030 | - | 21.8 | 339,648 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 531,840 | 795,241 | - | - | Stock Options (Right to Buy) | |
| Jon B. Rousseau | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 12 Jun 2025 | 531,840 | 1,715,973 | - | 6.4 | 3,387,821 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 21.75 per share. | 12 Jun 2025 | 531,840 | 1,184,133 | - | 21.8 | 11,567,520 | Common Stock |
| Bob Barnes | President, Community Living | Sale of securities on an exchange or to another person at price $ 21.75 per share. | 12 Jun 2025 | 30,730 | 39,269 | - | 21.8 | 668,378 | Common Stock |
| Bob Barnes | President, Community Living | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 12 Jun 2025 | 27,606 | 69,999 | - | 6.4 | 175,850 | Common Stock |
| Bob Barnes | President, Community Living | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 27,606 | 78,387 | - | - | Stock Options (Right to Buy) | |
| Mike McMaude | See Remarks | Sale of securities on an exchange or to another person at price $ 21.75 per share. | 12 Jun 2025 | 119,298 | 207,590 | - | 21.8 | 2,594,732 | Common Stock |
| Lisa Nalley | See Remarks | Sale of securities on an exchange or to another person at price $ 21.75 per share. | 12 Jun 2025 | 14,415 | 131,150 | - | 21.7 | 313,526 | Common Stock |
| Lisa Nalley | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 14,415 | 91,578 | - | - | Stock Options (Right to Buy) | |
| Lisa Nalley | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 12 Jun 2025 | 14,415 | 145,565 | - | 6.4 | 91,824 | Common Stock |
| Jennifer Phipps | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 15,616 | 90,377 | - | - | Stock Options (Right to Buy) | |
| Jennifer Phipps | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 12 Jun 2025 | 15,616 | 245,646 | - | 6.4 | 99,474 | Common Stock |
| Steven B. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 11,912 | 22,620 | - | 0 | Common Stock | |
| Timothy A. Wicks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 11,912 | 20,521 | - | 0 | Common Stock | |
| Olivia F. Kirtley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 11,912 | 32,014 | - | 0 | Common Stock | |
| Timothy A. Wicks | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.87 per share. | 03 May 2025 | 7,044 | 8,609 | - | 20.9 | 147,008 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.55 per share. | 25 Apr 2025 | 48,887 | 1,184,133 | - | 16.6 | 809,080 | Common Stock |
| Jennifer Phipps | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 183,374 | 183,374 | - | - | Stock Options (Right to Buy) | |
| Jennifer Phipps | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 86,356 | 230,030 | - | 0 | Common Stock | |
| Lisa Nalley | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 97,800 | 97,800 | - | - | Stock Options (Right to Buy) | |
| Lisa Nalley | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 46,057 | 131,150 | - | 0 | Common Stock | |
| Jennifer Yowler | President, PharMerica | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 48,900 | 48,900 | - | - | Stock Options (Right to Buy) | |
| Jennifer Yowler | President, PharMerica | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 23,029 | 75,401 | - | 0 | Common Stock | |
| Jon B. Rousseau | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 345,424 | 1,233,020 | - | 0 | Common Stock | |
| Jon B. Rousseau | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 733,496 | 733,496 | - | - | Stock Options (Right to Buy) | |
| Jennifer Phipps | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.82 per share. | 25 Jan 2025 | 21,944 | 143,674 | - | 22.8 | 500,762 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.82 per share. | 25 Jan 2025 | 44,362 | 887,596 | - | 22.8 | 1,012,341 | Common Stock |
| Jim Mattingly | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.82 per share. | 25 Jan 2025 | 12,115 | 122,665 | - | 22.8 | 276,464 | Common Stock |
| Jennifer Yowler | President, PharMerica | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.82 per share. | 25 Jan 2025 | 8,508 | 52,372 | - | 22.8 | 194,153 | Common Stock |
| Bob Barnes | President, Community Living | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.82 per share. | 25 Jan 2025 | 7,351 | 42,393 | - | 22.8 | 167,750 | Common Stock |
| Mike McMaude | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.82 per share. | 25 Jan 2025 | 7,202 | 326,888 | - | 22.8 | 164,350 | Common Stock |
| Lisa Nalley | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.82 per share. | 25 Jan 2025 | 14,501 | 85,093 | - | 22.8 | 330,913 | Common Stock |
| Steven B. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2024 | 10,708 | 10,708 | - | 0 | Common Stock | |
| Jon B. Rousseau | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.50 per share. | 25 Oct 2024 | 36,740 | 931,958 | - | 15.5 | 569,470 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.09 per share. | 25 Jul 2024 | 20,198 | 968,698 | - | 12.1 | 244,194 | Common Stock |
| Matthew D’Ambrosio | Director | Purchase of securities on an exchange or from another person at price $ 11.46 per share. | 20 May 2024 | 1,000 | 1,000 | - | 11.5 | 11,461 | Common Stock |
| Olivia F. Kirtley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2024 | 4,449 | 20,102 | - | 0 | Common Stock | |
| Timothy A. Wicks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 15,653 | 15,653 | - | 0 | Common Stock | |
| Olivia F. Kirtley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 15,653 | 15,653 | - | 0 | Common Stock | |
| Jon B. Rousseau | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.41 per share. | 25 Apr 2024 | 36,740 | 988,896 | - | 10.4 | 382,463 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 8.09 per share. | 15 Mar 2024 | 18,400 | 1,025,636 | - | 8.1 | 148,856 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 8.09 per share. | 15 Mar 2024 | 18,400 | 369,763 | - | 8.1 | 148,856 | Common Stock |
| Jim Mattingly | See Remarks | 15 Mar 2024 | 6,080 | 134,780 | - | 8.3 | 50,221 | Common Stock | |
| Jennifer Yowler | President, PharMerica | Purchase of securities on an exchange or from another person at price $ 8.21 per share. | 15 Mar 2024 | 3,000 | 60,880 | - | 8.2 | 24,630 | Common Stock |
| Jon B. Rousseau | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 8.12 per share. | 14 Mar 2024 | 37,405 | 1,007,236 | - | 8.1 | 303,729 | Common Stock |
| Jim Mattingly | See Remarks | 14 Mar 2024 | 12,280 | 128,700 | - | 8.2 | 100,450 | Common Stock | |
| Jennifer Phipps | Chief Accounting Officer | Purchase of securities on an exchange or from another person at price $ 8.14 per share. | 14 Mar 2024 | 12,300 | 165,618 | - | 8.1 | 100,122 | Common Stock |
| Jennifer Yowler | President, PharMerica | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 17,665 | 52,996 | - | - | Stock Options (Right to Buy) | |
| Jennifer Phipps | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 52,509 | 52,509 | - | - | Stock Options (Right to Buy) | |
| Jennifer Phipps | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 144,682 | 153,318 | - | 0 | Common Stock | |
| Jennifer Phipps | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 35,331 | 105,993 | - | - | Stock Options (Right to Buy) | |
| Steven S. Reed | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 19,837 | 19,837 | - | - | Stock Options (Right to Buy) | |
| Steven S. Reed | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 54,658 | 93,914 | - | 0 | Common Stock | |
| Steven S. Reed | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 60,847 | 182,543 | - | - | Stock Options (Right to Buy) | |
| Jim Mattingly | See Remarks | 25 Jan 2024 | 184,506 | 553,520 | - | - | Stock Options (Right to Buy) | ||
| Jim Mattingly | See Remarks | 25 Jan 2024 | 77,164 | 116,420 | - | 0 | Common Stock | ||
| Jim Mattingly | See Remarks | 25 Jan 2024 | 28,005 | 28,005 | - | - | Stock Options (Right to Buy) | ||
| Jennifer Yowler | President, PharMerica | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 17,665 | 52,996 | - | - | Stock Options (Right to Buy) | |
| Jennifer Phipps | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 5,888 | 17,655 | - | - | Stock Options (Right to Buy) | |
| Jennifer Yowler | President, PharMerica | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 21,004 | 21,004 | - | - | Stock Options (Right to Buy) | |
| Jennifer Yowler | President, PharMerica | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 57,880 | 57,880 | - | 0 | Common Stock | |
| Bob Barnes | President, Community Living | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 2,944 | 8,832 | - | - | Stock Options (Right to Buy) | |
| Bob Barnes | President, Community Living | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 46,620 | 49,744 | - | 0 | Common Stock | |
| Bob Barnes | President, Community Living | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 35,331 | 105,993 | - | - | Stock Options (Right to Buy) | |
| Bob Barnes | President, Community Living | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 16,919 | 16,919 | - | - | Stock Options (Right to Buy) | |
| Mike McMaude | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 18,670 | 18,670 | - | - | Stock Options (Right to Buy) | |
| Mike McMaude | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 51,442 | 334,090 | - | 0 | Common Stock | |
| Mike McMaude | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 33,349 | 103,048 | - | - | Stock Options (Right to Buy) | |
| Lisa Nalley | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 96,454 | 99,594 | - | 0 | Common Stock | |
| Lisa Nalley | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 3,925 | 11,777 | - | - | Stock Options (Right to Buy) | |
| Lisa Nalley | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 35,006 | 35,006 | - | - | Stock Options (Right to Buy) | |
| Lisa Nalley | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 35,331 | 105,993 | - | - | Stock Options (Right to Buy) |